Logo image of QNTM

QUANTUM BIOPHARMA LTD (QNTM) Stock Overview

NASDAQ:QNTM - CA74764Y2050 - Common Stock

14.3313 USD
-1.37 (-8.72%)
Last: 9/4/2025, 3:02:21 PM

QNTM Key Statistics, Chart & Performance

Key Statistics
52 Week High38.25
52 Week Low2.7
Market Cap54.75M
Shares3.82M
Float3.40M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)N/A
PEN/A
Fwd PEN/A
Earnings (Next)11-10 2025-11-10
IPO05-29 2018-05-29
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


QNTM short term performance overview.The bars show the price performance of QNTM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 50 100 150 200

QNTM long term performance overview.The bars show the price performance of QNTM in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150 200 250

The current stock price of QNTM is 14.3313 USD. In the past month the price decreased by -36.1%. In the past year, price increased by 282.93%.

QUANTUM BIOPHARMA LTD / QNTM Daily stock chart

QNTM Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 46 703.18B
JNJ JOHNSON & JOHNSON 17.82 429.09B
AZN ASTRAZENECA PLC-SPONS ADR 18.4 253.32B
NVO NOVO-NORDISK A/S-SPONS ADR 14.41 249.79B
NVS NOVARTIS AG-SPONSORED ADR 14.54 249.02B
MRK MERCK & CO. INC. 10.88 209.20B
PFE PFIZER INC 7.23 139.44B
SNY SANOFI-ADR 10.3 111.04B
BMY BRISTOL-MYERS SQUIBB CO 6.97 95.43B
GSK GSK PLC-SPON ADR 8.77 79.53B
ZTS ZOETIS INC 24.57 67.73B
TAK TAKEDA PHARMACEUTIC-SP ADR 52.76 48.32B

About QNTM

Company Profile

QNTM logo image Quantum BioPharma Ltd. is a biopharmaceutical company, which engages in building a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory, metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-05-29. The firm is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc., it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. The firm has also licensed unbuzzd, a formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of quickly relieving individuals from the effects of alcohol consumption. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

Company Info

QUANTUM BIOPHARMA LTD

55 University Ave. , Suite 1003

TORONTO ONTARIO CA

Employees: 10

QNTM Company Website

QNTM Investor Relations

Phone: 14168548884

QUANTUM BIOPHARMA LTD / QNTM FAQ

What is the stock price of QUANTUM BIOPHARMA LTD today?

The current stock price of QNTM is 14.3313 USD. The price decreased by -8.72% in the last trading session.


What is the ticker symbol for QUANTUM BIOPHARMA LTD stock?

The exchange symbol of QUANTUM BIOPHARMA LTD is QNTM and it is listed on the Nasdaq exchange.


On which exchange is QNTM stock listed?

QNTM stock is listed on the Nasdaq exchange.


What is QUANTUM BIOPHARMA LTD worth?

QUANTUM BIOPHARMA LTD (QNTM) has a market capitalization of 54.75M USD. This makes QNTM a Micro Cap stock.


How many employees does QUANTUM BIOPHARMA LTD have?

QUANTUM BIOPHARMA LTD (QNTM) currently has 10 employees.


What are the support and resistance levels for QUANTUM BIOPHARMA LTD (QNTM) stock?

QUANTUM BIOPHARMA LTD (QNTM) has a resistance level at 25.9. Check the full technical report for a detailed analysis of QNTM support and resistance levels.


Should I buy QUANTUM BIOPHARMA LTD (QNTM) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does QUANTUM BIOPHARMA LTD (QNTM) stock pay dividends?

QNTM does not pay a dividend.


When does QUANTUM BIOPHARMA LTD (QNTM) report earnings?

QUANTUM BIOPHARMA LTD (QNTM) will report earnings on 2025-11-10.


What is the Short Interest ratio of QUANTUM BIOPHARMA LTD (QNTM) stock?

The outstanding short interest for QUANTUM BIOPHARMA LTD (QNTM) is 2.42% of its float. Check the ownership tab for more information on the QNTM short interest.


QNTM Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to QNTM. When comparing the yearly performance of all stocks, QNTM is one of the better performing stocks in the market, outperforming 97.9% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

QNTM Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

QNTM Forecast & Estimates


Analysts
Analysts82.86
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

QNTM Ownership

Ownership
Inst Owners2.67%
Ins Owners8.89%
Short Float %2.42%
Short Ratio0.37